SMALL CELL LUNG CANCER ( SCLC )
Clinical trials for SMALL CELL LUNG CANCER ( SCLC ) explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER ( SCLC ) trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER ( SCLC ), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise against tough cancers
Disease control Recruiting nowThis study tests an experimental drug called CP-383 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find the safest dose and see if the drug can shrink or slow cancer growth. About 150 participants will take CP-383 daily …
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Phase: PHASE1, PHASE2 • Sponsor: Tasca Therapeutics • Aim: Disease control
Last updated Apr 29, 2026 01:43 UTC
-
New radiation drug targets cancer cells in advanced tumors
Disease control Recruiting nowThis early-phase study tests a new drug called 177Lu-RAD204 in people with advanced solid tumors (like lung, breast, or skin cancer) that have not responded to other treatments. The drug delivers a small amount of radiation directly to cancer cells by targeting a protein called P…
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Phase: EARLY_PHASE1 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Disease control
Last updated Apr 29, 2026 01:37 UTC
-
Engineered immune cells take on hard-to-treat lung cancer
Disease control Recruiting nowThis study tests a new treatment using specially designed natural killer (NK) cells to attack small cell lung cancer that has come back or not responded to standard therapy. About 60 adults aged 18-75 with advanced disease will receive these cells through an IV. The goal is to fi…
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Apr 29, 2026 01:35 UTC